SKAGI: Uppgjör Skaga á 2. ársfjórðungi 2026

Skaga hf. reported 2Q26 profit of 731 m.kr. after tax (vs. 972 m.kr. in 2Q25) and pre-tax operating profit of 1,181 m.kr., with return on equity down to 12.9% from 18.4%. Insurance remains solid (combined ratio 82.8%), but financial-services earnings turned negative with net financial-services profit of -95 m.kr. before tax and investment income below expectations (investment returns 0.8%, net investment income -144 m.kr.). The company updated 2026 outlook: combined ratio 90–93% (target <91.5%), financial-services revenues 2,700–3,200 m.kr. (target >2,900 m.kr.), and is guiding expected investment yield of 9.5%; shareholders received 1,792 m.kr. in buybacks and dividends in 1H26.

Analysis

The investable core here is still the insurance book, not the noisy mark-to-market line items. When underwriting is running materially better than the implied hurdle and costs are being structurally reset, the equity should trade more like a cash compounder than a market-sensitive financial. That argues for a lower discount rate over 6-18 months if management actually delivers the announced run-rate savings.

The weak spot is the capital-markets/asset-management franchise, which looks cyclical and fee-sensitive at exactly the wrong point in the cycle. If local issuance, M&A, and trading activity stay muted for another 1-2 quarters, this segment can remain an earnings drag even if insurance stays solid, limiting the speed of any rerating. Separate from that, illiquid valuation marks can keep headline results volatile and prevent investors from confidently capitalizing “underlying” earnings.

Contrarian take: the market may be overpricing the recent investment losses as a sign of deteriorating franchise quality, when the bigger structural issue is actually mix shift toward lower-margin, higher-volatility financial services. The more important falsifier is not one quarter of bad marks; it is any slippage in underwriting discipline or a reversal in the cost-cutting glide path. If the next two quarters fail to show a cleaner run-rate in costs and finance fees, the stock deserves to stay at a discount despite strong solvency and capital returns.

Key Decisions for Investors

• Buy Skagi on weakness over the next 1-4 weeks only if the market is pricing the quarter as a structural miss; the risk/reward improves if management confirms the ~300 m.kr. annual cost savings is a 2H run-rate, not a one-off. Falsifier: combined ratio moving back above 93% or no evidence of expense reduction in the next update.
• Use a pair mindset: long Skagi vs. a more fee-dependent Icelandic financial-services/brokerage exposure if available in your book, because underwriting should be less cyclical than advisory revenue. This is a relative-value trade for 1-3 months, not a macro call.
• Avoid chasing a full rerating until the investment-mark volatility compresses; if you need exposure, scale in after the next quarter confirms that the finance segment has stabilized and that the guidance cut was conservative. Upside is cleaner if equity-market marks stop dragging reported earnings.
• Set a watch item on solvency and capital return cadence: if buybacks/dividends continue while solvency stays near 1.3, downside should be cushioned; if capital returns slow without a matching improvement in growth, the stock may be telling you excess capital is less abundant than it appears.